Literature DB >> 2217010

An evaluation of combining thiopentone and etomidate for the induction of anaesthesia.

R M Slater1, B J Pollard, T M Young, L P Hunt.   

Abstract

The characteristics of three combinations of thiopentone and etomidate [in the ratios of thiopentone (mg):etomidate (mg) of 5:1, 13:1 and 25:1] have been compared with the individual agents alone for the induction of anaesthesia. The incidence of pain on injection and abnormal movements was less with the combination containing the highest ratio of thiopentone to etomidate, when compared to etomidate alone. The mixtures did not otherwise confer any advantages over the individual agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217010      PMCID: PMC2429629          DOI: 10.1136/pgmj.66.777.539

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  The prevention of etomidate-induced myoclonus.

Authors:  S S Lowe
Journal:  Anaesthesia       Date:  1984-01       Impact factor: 6.955

2.  Sequential use of thiopentone and etomidate in anaesthesia for termination of pregnancy.

Authors:  J M Cundy; W E Scott
Journal:  Anaesthesia       Date:  1983-02       Impact factor: 6.955

3.  Etomidate: a foreshortened clinical trial.

Authors:  P M Yelavich; C M Holmes
Journal:  Anaesth Intensive Care       Date:  1980-11       Impact factor: 1.669

4.  Etomidate: an 'immunologically safe' anaesthetic agent.

Authors:  J Watkins
Journal:  Anaesthesia       Date:  1983-07       Impact factor: 6.955

5.  Etomidate, a new water-soluble non-barbiturate intravenous induction agent.

Authors:  M Morgan; J Lumley; J G Whitwam
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.